Erik A. Wist

1.1k total citations
21 papers, 804 citations indexed

About

Erik A. Wist is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Erik A. Wist has authored 21 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Erik A. Wist's work include Breast Cancer Treatment Studies (7 papers), Cancer Risks and Factors (6 papers) and Cancer, Lipids, and Metabolism (3 papers). Erik A. Wist is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Risks and Factors (6 papers) and Cancer, Lipids, and Metabolism (3 papers). Erik A. Wist collaborates with scholars based in Norway, United States and Germany. Erik A. Wist's co-authors include Terje Risberg, Jan Norum, Sveinung Wergeland Sørbye, Roy M. Bremnes, Olbjørn Klepp, Olav Dahl, Marianne Brydøy, Sophie D. Fosså, Tore Wentzel‐Larsen and Inger Thune and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and European Urology.

In The Last Decade

Erik A. Wist

18 papers receiving 781 citations

Peers

Countries citing papers authored by Erik A. Wist

Since Specialization

Citations

This map shows the geographic impact of Erik A. Wist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Wist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Wist more than expected).

Fields of papers citing papers by Erik A. Wist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Wist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Wist. The network helps show where Erik A. Wist may publish in the future.

Co-authorship network of co-authors of Erik A. Wist

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Wist. A scholar is included among the top collaborators of Erik A. Wist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Wist. Erik A. Wist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study 2022 ·Acta Oncologica ·(unknown), Hanne Frydenberg, Marit B. Veierød, Anne Karen Jenum, Jon B. Reitan, Erik A. Wist, Inger Thune	1
2	Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes 2018 ·BMC Cancer ·(unknown), Elin Mortensen, Hawa Nalwoga, Tom Wilsgaard, Hanne Frydenberg, Terje Risberg, Anne Elise Eggen, Anne McTiernan, (unknown), Erik A. Wist, Andreas Stensvold, Jon B. Reitan, Lars A. Akslen, Inger Thune	66
3	Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up 2017 ·Breast Cancer Research ·Hege O. Ohnstad, Elin Borgen, Ragnhild Sørum Falk, Tonje G. Lien, (unknown), (unknown), Jon Amund Kyte, Vessela N. Kristensen, Gry Aarum Geitvik, Ellen Schlichting, Erik A. Wist, Thérese Sørlie, Hege G. Russnes, Bjørn Naume	84
4	Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer 2017 ·npj Breast Cancer ·Charlotte Vaysse, Jon Lømo, Øystein Garred, (unknown), (unknown), Ellen Schlichting, Anne McTiernan, Hanne Frydenberg, (unknown), Steinar Lundgren, Morten Wang Fagerland, Elin Richardsen, Erik A. Wist, Catherine Muller, Inger Thune	64
5	Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer 2016 ·Lipids in Health and Disease ·Vidar G. Flote, Riyas Vettukattil, Tone F. Bathen, Thore Egeland, Anne McTiernan, Hanne Frydenberg, (unknown), (unknown), Jon Lømo, Øystein Garred, Ellen Schlichting, Erik A. Wist, Inger Thune	29
6	High-Density Lipoprotein-Cholesterol, Daily Estradiol and Progesterone, and Mammographic Density Phenotypes in Premenopausal Women 2015 ·Cancer Prevention Research ·Vidar G. Flote, Hanne Frydenberg, Giske Ursin, Anita Iversen, Morten Wang Fagerland, Peter T. Ellison, Erik A. Wist, Thore Egeland, Tom Wilsgaard, Anne McTiernan, Anne-Sofie Furberg, Inger Thune	9
7	Molecular characteristics in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva— Randomized phase II study. 2015 ·Journal of Clinical Oncology ·Olav Engebraaten, Laxmi Silwal‐Pandit, (unknown), Silje Nord, Marit Krohn, Hans Kristian Moen Vollan, (unknown), Elin Borgen, Øystein Garred, Anne Fangberget, Marit Muri Holmen, Steinar Lundgren, Erik A. Wist, Ole Christian Lingjærde, Bjørn Naume, Anne‐Lise Børresen‐Dale	0
8	Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women 2014 ·Breast Cancer Research ·Vidar G. Flote, Anne-Sofie Furberg, Anne McTiernan, Hanne Frydenberg, Giske Ursin, Anita Iversen, (unknown), Peter T. Ellison, Erik A. Wist, Thore Egeland, Tom Wilsgaard, Karen W. Makar, Jenny Chang‐Claude, Inger Thune	10
9	Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer 2014 ·Journal of Clinical Oncology ·Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk, Gro Wiedswang, (unknown), Terje Risberg, Christian Kersten, Ingvil Mjaaland, (unknown), (unknown), Anna Barbro Sætersdal, (unknown), Cecilie Bendigtsen Schirmer, Erik A. Wist, Elin Borgen	66
10	Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy 2010 ·European Urology ·Marianne Brydøy, Sophie D. Fosså, Olbjørn Klepp, Roy M. Bremnes, Erik A. Wist, Tore Wentzel‐Larsen, Olav Dahl	55
11	Adult Height, Insulin, and 17β-Estradiol in Young Women 2009 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Aina Emaus, Steinar Tretli, Grażyna Jasieńska, Peter T. Ellison, Anne-Sofie Furberg, Erik A. Wist, Inger Thune	11
12	Paternity Following Treatment for Testicular Cancer 2005 ·JNCI Journal of the National Cancer Institute ·Marianne Brydøy, Sophie D. Fosså, Olbjørn Klepp, Roy M. Bremnes, Erik A. Wist, Tore Wentzel‐Larsen, Olav Dahl	167
13	Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer 2004 ·Acta Oncologica ·Erik A. Wist, (unknown), Bjørn Østenstad, Terje Risberg, Yngve Bremnes, (unknown)	50
14	Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer 2004 ·Acta Oncologica ·Erik A. Wist, (unknown), Bjørn Østenstad, Terje Risberg, (unknown)	20
15	[Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]. 2003 ·PubMed ·Terje Risberg, Arne Kolstad, Erik A. Wist, Harald Holte, Olav Mella, Olbjørn Klepp	0
16	[Does use of alternative medicine aggravate the survival prognosis in cancer?]. 2003 ·PubMed ·Terje Risberg, Roy M. Bremnes, Andrew J. Vickers, Erik A. Wist, Stein Kaasa	1
17	Lumpectomy or mastectomy? Is breast conserving surgery too expensive? 1997 ·Breast Cancer Research and Treatment ·Jan Norum, Jan Abel Olsen, Erik A. Wist	39
18	HOYDOSEBEHANDLING MED AUTOLOG STAMCELLESTOTTE VED MALIGNE LIDELSER 1996 ·Tidsskrift for Den Norske Laegeforening ·Harald Holte, Stein Kvaløy, Terje Engan, Stein A. Evensen, Olav Mella, Jon Magnus Tangen, Finn Wesenberg, Erik A. Wist	1
19	[Attitudes to treatment with cytostatic agents. Do cancer patients, physicians, nurses and healthy individuals vary in their views?]. 1996 ·PubMed ·Roy M. Bremnes, Erik A. Wist, Kristin Andersen	1
20	Diagnostic delay causes more psychological distress in female than in male cancer patients. 1996 ·PubMed ·Terje Risberg, Sveinung Wergeland Sørbye, Jan Norum, Erik A. Wist	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact